ODDB.org: Open Drug Database

Novartis Pharma Schweiz AG - Xolair 150 mg/1.0 ml, Injektionslösung in einer Fertigspritze

Swissmedic Registration	68030	Sequence	02
Product name	Xolair 150 mg/1.0 ml	Description	Injektionslösung in einer Fertigspritze
ATC-Classification	R03DX05	ATC-Description	Omalizumab
Introduction of Sequence	08.04.2021

Composition

omalizumabum 150.00 mg, arginini hydrochloridum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1.00 ml.

Packungsbestandteile

Galenic Form

Injection solution in prefilled syringe

Excipiens

Active Agent	Dose
Omalizumab	150mg / 1ml

BAG: Active Agent	Dose
Omalizumab	150 mg

Inactive agents
Arginine Hydrochloride
Histidin Hydrochloride Monohydrate
Histidine
Polysorbatum 20

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
002		375.83	425.15	B	SL	Yes
005		375.83	425.15	B	SL	No

2025	©ywesee GmbH